Search

Your search keyword '"Björn E. Wahlin"' showing total 5 results
Start Over Author "Björn E. Wahlin" Publisher elsevier bv
5 results on '"Björn E. Wahlin"'

3. Poster: IBCL-131: inMIND: A Phase 3 Study of Tafasitamab + Lenalidomide Add-On to Rituximab vs Placebo + Lenalidomide Add-On to Rituximab for Relapsed/Refractory (R/R) Follicular Lymphoma (FL) or Marginal Zone Lymphoma (MZL)

Author

Laurie H. Sehn, Christian W. Scholz, Stefano Luminari, Antonio Salar, Björn E. Wahlin, Ajay K. Gopal, Christophe Bonnet, Marek Trneny, Shankara Paneesha, Oliver Manzke, Francis Seguy, Di Li, and Kai Hübel

Subjects
Cancer Research, Oncology, Hematology
Published
2021

4. Morbidity, Mortality and Normality after Autologous Stem-Cell Transplantation for Lymphoma: A Comprehensive, Single-Centre, Population-Based, Real-World Analysis of Patients Transplanted 1994-2016

Author

Björn E. Wahlin, Martin Jädersten, Kristina Sonnevi, Karin Littmann, Henna Riikka Junlén, Per Ljungman, Bo Björkstrand, Christopher M. Melén, Anna Hellström, and Mattias Carlsten

Subjects
medicine.medical_specialty, Chemotherapy, business.industry, Nausea, medicine.medical_treatment, Transplantation, Clinical research, Autologous stem-cell transplantation, Internal medicine, Intensive care, Vomiting, Medicine, medicine.symptom, business, Aprepitant, medicine.drug
Abstract

Background: Autologous stem-cell transplantation (ASCT) is established lymphoma therapy, but the procedure has a substantial treatment-related mortality. Methods All 433 lymphoma patients who underwent ASCT at Karolinska Huddinge 1994-2016 were investigated, including long- and short-term mortality, causes of death, longitudinal laboratory values and anti-lymphoma treatments, harvested and transplanted CD34 cell amounts, infectious and other complications, microbiology findings, intensive care, drugs administered, chemotherapy-induced nausea, hospital stay, and secondary myeloid neoplasia. Findings: BEAM was the conditioning for 93%. The 100-day overall and non-lymphoma mortality were 7·2% and 5·6%. Stem cell harvests

Published
2018

Catalog

Books, media, physical & digital resources
See catalog results